Ferric carboxymaltose therapy reduces symptoms and improves quality of life in patients who have heart failure with a reduced ejection fraction and iron deficiency. Additional evidence about the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback